| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.12B | +10.1% |
| Cost of Revenue | $15.23B | +5.7% |
| Gross Profit | $8.89B | +18.4% |
| R&D Expense | $2.91B | +7.1% |
| SG&A Expense | $2.15B | -2.7% |
| Operating Income | $892.3M | +420.0% |
| Interest Expense | $165.5M | — |
| Pre-tax Income | $1.36B | +4756.9% |
| Income Tax | -$1.51B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.08B | +61.6% |
| Accounts Receivable | $148.9M | +10.4% |
| Inventory | $105.0M | -4.6% |
| Current Assets | $19.88B | +5.4% |
| Total Assets | $36.78B | +7.9% |
| Current Liabilities | $8.55B | -13.9% |
| Total Liabilities | $15.54B | +1.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.71B | +1591.1% |
| Capital Expenditures | $153.9M | +1.8% |
| Investing Cash Flow | $650.0M | -4.9% |
| Financing Cash Flow | $1.95B | +913.1% |
| Free Cash Flow | $1.55B | +3195.0% |
| — |
| Net Income | $2.90B | — |
| EPS (Basic) | $4.70 | — |
| EPS (Diluted) | $4.56 | — |
| Stockholders' Equity |
| $21.27B |
| +13.8% |